A Study Measuring the Effectiveness, Safety, and Tolerability of BMS-986278 in Participants With Lung Fibrosis

Trial ID or NCT#

NCT04308681

Status

not recruiting iconNOT RECRUITING

Purpose

The purpose of this study is to provide an initial evaluation of the effectiveness of BMS-986278 in participants with lung fibrosis, to demonstrate the safety of BMS-986278, and provide information on the drug levels of BMS-986278 in these participants.

Official Title

A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study of the Efficacy and the Safety and Tolerability of BMS-986278 in Participants With Pulmonary Fibrosis

Eligibility Criteria

Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Show Less

Investigator(s)

Rishi Raj
Rishi Raj
Pulmonologist
Clinical Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine

Contact us to find out if this trial is right for you.

Contact

Rishi Raj, Site 0043
650-736-8083

View on ClinicalTrials.gov